Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$152M |
| 2 |
AT&T
T
|
+$119M |
| 3 |
Norfolk Southern
NSC
|
+$117M |
| 4 |
CSX Corp
CSX
|
+$115M |
| 5 |
Booking.com
BKNG
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$156M |
| 3 |
C.H. Robinson
CHRW
|
+$134M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$130M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.4% |
| 2 | Industrials | 9.75% |
| 3 | Financials | 7.9% |
| 4 | Consumer Staples | 7.89% |
| 5 | Healthcare | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
CALL
Zoetis
ZTS
$31.9B
| $8.87M | 0.05% |
+200,000
| New | +$8.49M |
|
|
CADE
427
DELISTED
Cadence Bank
CADE
| $8.87M | 0.05% |
415,991
+138,356
| +50% | +$2.87M |
|
428
PUT
Trip.com Group
TCOM
$29B
| $8.85M | 0.05% |
+200,000
| New | +$8.37M |
|
429
Honeywell
HON
$67.8B
| $8.84M | 0.05% |
87,835
-34,493
| -28% | -$3.23M |
|
430
Shopify
SHOP
$193B
| $8.78M | 0.05% |
+3,112,280
| New | +$7.37M |
|
431
CALL
Under Armour
UAA
$2.32B
| $8.76M | 0.05% |
+400,000
| New | +$15.8M |
|
432
PUT
Signet Jewelers
SIG
$3.24B
| $8.68M | 0.05% |
70,000
-30,000
| -30% | -$3.41M |
|
433
iShares MSCI Emerging Markets ETF
EEM
$30.6B
| $8.56M | 0.05% |
250,000
+25,000
| +11% | +$774K |
|
|
ATHN
434
DELISTED
Athenahealth, Inc.
ATHN
| $8.53M | 0.05% |
+61,447
| New | +$8.43M |
|
|
WR
435
DELISTED
Westar Energy Inc
WR
| $8.52M | 0.05% |
171,807
+33,407
| +24% | +$1.49M |
|
|
LPNT
436
DELISTED
LifePoint Health, Inc.
LPNT
| $8.52M | 0.05% |
123,050
+113,897
| +1,244% | +$7.6M |
|
437
Restaurant Brands International
QSR
$28.2B
| $8.46M | 0.05% |
217,896
+205,685
| +1,684% | +$7.15M |
|
|
ANAC
438
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $8.44M | 0.05% |
157,843
+155,693
| +7,242% | +$11.5M |
|
|
SLCA
439
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $8.37M | 0.05% |
+368,567
| New | +$6.84M |
|
440
DaVita
DVA
$11.1B
| $8.35M | 0.05% |
113,800
-289,111
| -72% | -$19.5M |
|
441
CALL
Citigroup
C
$221B
| $8.35M | 0.05% |
+200,000
| New | +$8.36M |
|
|
WUBA
442
PUT
DELISTED
58.com Inc
WUBA
| $8.35M | 0.05% |
+150,000
| New | +$8.29M |
|
|
SGNT
443
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $8.33M | 0.05% |
684,585
+644,854
| +1,623% | +$9.04M |
|
444
Spectrum Brands
SPB
$2.03B
| $8.32M | 0.05% |
76,143
-46,569
| -38% | -$4.59M |
|
445
Herc Holdings
HRI
$5.38B
| $8.32M | 0.05% |
263,377
-153,409
| -37% | -$4.51M |
|
446
Columbia Sportswear
COLM
$3.11B
| $8.3M | 0.05% |
+138,090
| New | +$7.58M |
|
447
AXIS Capital
AXS
$7.33B
| $8.25M | 0.05% |
148,763
+115,161
| +343% | +$6.23M |
|
448
Southwest Gas
SWX
$6.45B
| $8.21M | 0.05% |
+124,719
| New | +$7.51M |
|
449
Monarch Casino & Resort
MCRI
$2.24B
| $8.2M | 0.05% |
421,279
+6,293
| +2% | +$126K |
|
450
Globe Life
GL
$13.4B
| $8.12M | 0.05% |
+149,966
| New | +$7.99M |
|
Similar funds
Dmitry Balyasny's Q1 2016 Portfolio in Review
As of Q1 2016, Dmitry Balyasny held 1,764 positions worth $16.8B, up 17% from $14.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Dmitry Balyasny deployed $2.2B of net new capital in Q1 2016, opening 564 new positions and adding to 341 existing holdings. Its largest new stake was Norfolk Southern: 1,546,641 shares worth $129M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $187M trimmed.
- Dmitry Balyasny's largest Q1 2016 buy was Norfolk Southern: 1,546,641 shares worth $129M.
- Dmitry Balyasny added most to Marathon Petroleum in Q1 2016, an estimated $152M increase.
- Dmitry Balyasny's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $187M.
- Dmitry Balyasny fully exited Union Pacific in Q1 2016, selling an estimated $79.7M.
- Dmitry Balyasny's ten largest holdings make up 12% of its $16.8B portfolio in Q1 2016.
- Dmitry Balyasny opened 564 new positions and closed 526 in Q1 2016.
- Dmitry Balyasny's portfolio value rose 17% quarter-over-quarter to $16.8B.
Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.